In human DS patient fibroblasts, mouse models, and non-human primates, these ASOs upregulated SCN1A expression, restored Nav1.1 levels in fast-spiking inhibitory interneurons, normalized interneuron activity, and reduced seizure burden [7,23]. Here, SCN1A is linked to Dravet syndrome.